1New perspectives in liver diseases with challengesCalvin Q.Pan, Nancy Reau515-5162Noninvasive tests for liver fibrosis in 2024:are there different scales for different diseases?Jimmy Che-To Lai, Lilian Yan Liang, Grace Lai-Hung Wong517-5313Preoperative risk evaluation and optimization for patients with liver diseaseSameer Bhalla, Brendan Mcquillen, Edward Cay, Nancy Reau532-5434Advances in the management of complications from cirrhosisJasleen Singh, Mark Ebaid, Sammy Saab544-5555Postpartum hepatitis flares in mothers with chronic hepatitis B infectionShi OuYang, Yawen Geng, Gongqin Qiu, Yueying Deng, Haitao Deng, Calvin Q.Pan556-5676New perspectives in hepatocellular carcinoma surveillance after hepatitis C virus eradicationCalvin Q.Pan, Andrew J.Park, James S.Park568-5747Active role of the immune system in metabolic dysfunction-associated steatotic liver diseaseTaizo Mori, Sachiyo Yoshio, Eiji Kakazu, Tatsuya Kanto575-5858Advances in the management of alcohol-associated liver diseaseAhmad Anouti, Thomas A.Kerr, Mack C.Mitchell, Thomas G.Cotter586-6019Independent and additive effects of binge drinking and obesity on liver enzymes:a cross-sectional analysis using the Korean National Health Insurance Service dataAnthony Kityo, Sang-Ah Lee602-60910Association between low-normal thyroid function and advanced liver fibrosis in metabolic dysfunction-associated fatty liver disease patients:a retrospective cohort studyZixuan Li, Xiaoying Wu, Zebin Chen, Xiuqing Wei, Weiqing Chen610-61511Celiac artery mesenteric fat measurement with endosonography(CAMEUS)reliably correlates with obesity and related comorbiditiesFateh Bazerbachi, Serge Baroud, Michael J.Levy, Daniel B.Maselli, Eric J.Vargas, Aliana Bofill-Garcia, Ryan J.Law, Vinay Chandrasekhara, Andrew C.Storm, Ferga C.Gleeson, Elizabeth Rajan, Prasad G.Iyer, Kymberly D.Watt, Barham K.Abu Dayyeh616-62212HCV elimination:is the bulk of the iceberg being missed?Eric Kalo, Asma Baig, Alison Derrett, Scott Read, Golo Ahlenstiel623-624